Home / Companies / Futureceuticals / Trends
Futureceuticals H-1B trends
Quarterly LCA aggregate trend points for Futureceuticals. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Futureceuticals span 2020 Q2 to 2025 Q1, peaking at 1 filings in 2020 Q2.
The most recent reported period (2025 Q1) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2020 Q2 | 1 | 1 | 1 | $76,000 | $75,275 | 1 | 100.0% |
| 2023 Q3 | 1 | 1 | 1 | $80,000 | $72,738 | 1 | 100.0% |
| 2025 Q1 | 1 | 1 | 1 | $80,000 | $72,738 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Futureceuticals changed over time?
- H-1B LCA filings for Futureceuticals span 2020 Q2 to 2025 Q1, peaking at 1 filings in 2020 Q2. The most recent reported period (2025 Q1) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=futureceuticals&metric=lca_countJSON